+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 25Years - 75Years
All Genders
ID04929951

Comparing Micro Fragmented Adipose Tissue and Corticosteroid Injections for Shoulder Osteoarthritis Treatment

Led by Stanford University · Updated on 2026-08-17

48

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of intra-articular injections of Micro Fragmented Adipose Tissue MFAT compared with corticosteroid injections in patients with mild to moderate osteoarthritis of the shoulder. This randomized controlled trial focuses on clinical and functional outcomes to better understand treatment options for this condition. The study is a Phase 1 interventional trial sponsored by Stanford University. Participants will be randomly assigned to one of two groups. One group will receive an injection of MFAT, which is harvested from the thigh by lipoaspiration, minimally processed in the clinic, and then injected into the shoulder joint. The other group will receive a corticosteroid injection Triamcinolone 40mg into the shoulder. Both treatments are given as intra-articular injections targeting the glenohumeral joint. During the study, participants will undergo assessments including the ASES Shoulder Score, DASH Outcome Measure, and Veterans RAND 12 VR-12 score at 24 months to evaluate shoulder function and quality of life. Follow-up surveys may be completed online, by phone, or in person. The study monitors treatment effects and safety over two years, with participants expected to understand and comply with pre- and post-procedure care instructions throughout their involvement.

CONDITIONS

Brief Title

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here